| Article title |
Low complexity |
Vague/unclear |
Inaccurate |
Accurate/appropriate |
| Dysplastic nevus part I: historical perspective, classification, and epidemiology |
1 |
2 |
1 |
1 |
| Dysplastic nevus part II: dysplastic nevi: molecular/genetic profiles and management |
3 |
0 |
1 |
1 |
| Disorders of hyperpigmentation. Part I. Pathogenesis and clinical features of common pigmentary disorders |
1 |
2 |
2 |
0 |
| Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation |
2 |
1 |
0 |
2 |
| Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part I: calcineurin inhibitors, thiopurines, IMDH inhibitors, mTOR inhibitors, and corticosteroids |
2 |
1 |
1 |
1 |
| Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part II: methotrexate, alkylating agents, biologics, and small molecule inhibitors |
1 |
1 |
0 |
3 |
| Skin disorders and interstitial lung disease: part I - screening, diagnosis, and therapeutic principles |
0 |
1 |
0 |
4 |
| Skin disorders and interstitial lung disease: part II -the spectrum of cutaneous diseases with lung disease association |
0 |
1 |
0 |
4 |
| Total, n (%) |
10 (25) |
9 (22.5) |
5 (12.5) |
16 (40) |
